ArticleScientific reports2026
Application of a novel approach for dementia prevalence prediction in Taiwan.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Amid the rapidly aging global population, dementia cases are rising at an alarming rate. Dementia has become a major public health challenge, exerting profound impacts on socioeconomic systems and overall human well-being. The condition progressively deteriorates cognitive abilities such as memory, judgment, comprehension, and language, eventually resulting in the loss of independent daily functioning. In addition, patients often experience neuropsychiatric symptoms that severely diminish their quality of life. This study proposes an optimized machine learning model the Flying Geese Optimization Algorithm Support Vector Regression (FGOASVR) to effectively predict trends in dementia prevalence. The empirical analysis utilizes annual dementia diagnostic data from 1998 to 2023, obtained from Taiwan's National Health Insurance Research Database (NHIRD). To validate model performance, FGOASVR was compared against three categories of forecasting models: Statistical models: Autoregressive Integrated Moving Average (ARIMA) and Holt-Winters Exponential Smoothing (HWETS); Deep learning model: Long Short-Term Memory (LSTM); Hybrid models: Support Vector Regression (SVR), Particle Swarm Optimization SVR (PSOSVR), Differential Evolution SVR (DESVR), Whale Optimization Algorithm SVR (WOASVR), and Harris Hawk Optimization SVR (HHOSVR). Performance was assessed using standard forecasting metrics Mean Absolute Percentage Error (MAPE) and Root Mean Square Error (RMSE). The FGOASVR model achieved the highest accuracy, with average MAPE values of 3.17 and 3.42, and RMSE values of 0.69 and 0.96 for males and females, respectively. These results confirm that FGOASVR delivers superior precision and stability in forecasting dementia trends in Taiwan, demonstrating its strong potential for advancing data-driven public health prediction and policy development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.